Rebecca Scherzer, Ph.D. named as one of the top 5 reviewers for the Clinical section of JAIDS and as one of the best reviewers for Pharmacoepidemiology and Drug Safety

Dr. Scherzer was acknowledged by the editors of Pharmacoepidemiology and Drug Safety for the exceptionally fine quality of her peer reviewing of manuscripts submitted during 2014.

She was also informed that at the annual Editorial Board Meeting the top reviewers of 2014 were announced for JAIDS, the Journal of Acquired Immune Deficiency Syndromes. Dr. Scherzer was selected as one of the top 5 reviewers for the Clinical section of JAIDS.

Congratulations, Rebecca!